NEW DELHI: Pfizer and Glenmark Pharma have joined hands to launch abrocitinib, a first-of-its-kind oral advanced systemic treatment for moderate-to-severe atopic dermatitis (AD), in India ...

All findings were consistent with previous safety analyses for abrocitinib, researchers wrote. Co-author Justine Alderfer, PharmD is the senior medical director for dermatology at Pfizer ...

At the recent SEC meeting for Dermatology and Allergy held on 5th September 2024, the expert panel reviewed a proposal for a ...

Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The ...

But casually scrolling on the social-media site, one Monday early in the new year, he came across a video clip appearing to show the head of Pfizer suggesting his vaccine provided no protection at ...

Despite extremely promising results, Pfizer, the major funder of the work in alliance with California Biotechnology, abandoned the effort around 1991 after mistakenly concluding that the GLP-1 ...

Looking at Pfizer's recent performance in business turnaround, I think the recovery in PFE stock should continue in the medium term - the 10% total return since June 2024 may be just the beginning ...

Pfizer will receive around 2.66 billion pounds ($3.56 billion) in aggregate from Haleon from an offering and a share buyback. Goldman Sachs International said Tuesday that the pharmaceutical ...

Pfizer is a global pharmaceutical giant with an impressive portfolio of over 350 marketed medicines, 113 experimental candidates in clinical trials, and a presence in more than 200 countries.

Pfizer (PFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

Pfizer's RSI is trending upward, bouncing from the 50 support level, signaling potential stock strength and accumulation. Pfizer's KP.2-adapted COVID-19 vaccine received FDA approval, positioning ...

Some Pfizer investors are hungry for an encore and showing their displeasure by shunning the stock. The attitude has left the shares undervalued, in the opinion of one pundit (and his bullish view ...